The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The landscape of HIV prevention has undergone a profound transformation with significant advancements in medical interventions and a deeper understanding of how the virus spreads. These ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

Here’s what to know about the twice-yearly preventative HIV shot - A twice-yearly drug called lenacapavir is now the ...

A groundbreaking medical advancement could reshape the future of HIV prevention. In a landmark clinical trial, a twice-yearly injection of lenacapavir demonstrated an astonishing 96% effectiveness ...

HIV treatment as prevention, or TasP, means a person living with HIV takes medication to prevent passing the virus to someone who doesn’t have it. It also means you can maintain an undetectable ...

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

The Trump administration’s cuts to U.S. health agencies announced Tuesday will reduce HIV prevention services and hamper Georgia’s efforts to tackle stubbornly high rates of new infection ...

HOUSTON — The fight against HIV has come a long way, and new advancements in prevention are changing the game. One of the latest breakthroughs is a long-lasting injectable form of PrEP (pre ...

The Department of Health and Human Services (HHS) is reportedly poised to slash funding for domestic HIV prevention at the Centers for Disease Control and Prevention (CDC), The Wall Street Journal ...